- Home
- KMDA
KMDA
Kamada Ltd.
as 11-07-2025 3:55pm EST
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Upcoming Earnings Alert:
Get ready for potential market movements as Kamada Ltd. KMDA prepares to release earnings report on 10 Nov 2025.
| Founded: | 1990 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 398.5M | IPO Year: | N/A |
| Target Price: | $13.00 | AVG Volume (30 days): | 70.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | 0.32 | EPS Growth: | 27.97 |
| 52 Week Low/High: | $5.54 - $9.15 | Next Earning Date: | 11-10-2025 |
| Revenue: | $169,517,000 | Revenue Growth: | 9.67% |
| Revenue Growth (this year): | 14.49% | Revenue Growth (next year): | 10.12% |
Latest Kamada Ltd. News
KMDA Breaking Stock News: Dive into KMDA Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates
Zacks
2 days ago
Ocugen (OCGN) Reports Q3 Loss, Beats Revenue Estimates
Zacks
2 days ago
Should Value Investors Buy Kamada (KMDA) Stock?
GlobeNewswire
4 days ago
Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation
GlobeNewswire
5 days ago
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025
Zacks
7 days ago
KMDA vs. NVZMY: Which Stock Is the Better Value Option?
Zacks
8 days ago
Wall Street Analysts Believe Kamada (KMDA) Could Rally 113.15%: Here's is How to Trade
Zacks
16 days ago
3 Reasons Why Growth Investors Shouldn't Overlook Kamada (KMDA)
Compare KMDA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KMDA Kamada Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.